Literature DB >> 19260944

Serious psychological distress among persons with epilepsy based on the 2005 California Health Interview Survey.

J Layne Moore1, John O Elliott, Bo Lu, Emily T Klatte, Christine Charyton.   

Abstract

PURPOSE: To compare the prevalence of self-reported serious psychological distress using the Kessler 6 (K6) in persons with a history of epilepsy (PWE) to those without epilepsy from a population-based survey.
METHODS: Data were analyzed from adults aged >or=18 years (n = 43,020) who participated in the 2005 California Health Interview Survey (CHIS).
RESULTS: California adults with a history of epilepsy, after controlling for demographics and comorbidities, reported higher rates of feeling nervous [odds ratio (OR) 2.22], feeling hopeless (OR 1.35), feeling restless (OR 2.07), feeling depressed (OR 3.14), and feeling worthless (OR 2.57), and reported that everything has been an effort (OR 2.28) in the last 30 days. The K6 score showed that serious psychological distress is more common in PWE (OR 2.24). After adjusting for demographics, comorbidities, and serious psychological distress, PWE are more likely to report having 14 or more physical, mental, and general unhealthy days in the last 30 days. DISCUSSION: PWE have significantly higher rates of serious psychological distress and poor health-related quality of life after controlling for demographics, comorbidities. These comorbid conditions need to be factored into any comprehensive treatment strategy for managing PWE to achieve optimum quality of life.

Entities:  

Mesh:

Year:  2009        PMID: 19260944     DOI: 10.1111/j.1528-1167.2008.01996.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Toward a cancer-specific model of psychological distress: population data from the 2003-2005 National Health Interview Surveys.

Authors:  Natalie C Kaiser; Narineh Hartoonian; Jason E Owen
Journal:  J Cancer Surviv       Date:  2010-03-08       Impact factor: 4.442

Review 2.  Future directions for epidemiology in epilepsy.

Authors:  Christine Linehan; José F Tellez-Zenteno; Jorge G Burneo; Anne T Berg
Journal:  Epilepsy Behav       Date:  2011-08-04       Impact factor: 2.937

3.  Satisfaction with life domains in people with epilepsy.

Authors:  Rosemarie Kobau; Cecily Luncheon; Matthew M Zack; Ross Shegog; Patricia H Price
Journal:  Epilepsy Behav       Date:  2012-11-13       Impact factor: 2.937

Review 4.  Depression in epilepsy: a systematic review and meta-analysis.

Authors:  Kirsten M Fiest; Jonathan Dykeman; Scott B Patten; Samuel Wiebe; Gilaad G Kaplan; Colleen J Maxwell; Andrew G M Bulloch; Nathalie Jette
Journal:  Neurology       Date:  2012-11-21       Impact factor: 9.910

5.  A feasibility study to assess social stress and social support in patients enrolled in a cannabidiol (CBD) compassionate access program.

Authors:  Zachary H McCann; Magdalena Szaflarski; Jerzy P Szaflarski
Journal:  Epilepsy Behav       Date:  2021-09-29       Impact factor: 2.937

6.  Epilepsy care and mental health care for people with epilepsy: California Health Interview Survey, 2005.

Authors:  Alexander W Thompson; Rosemarie Kobau; Royce Park; David Grant
Journal:  Prev Chronic Dis       Date:  2012-02-23       Impact factor: 2.830

7.  Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  R C Kessler; M C Lane; V Shahly; P E Stang
Journal:  Mol Psychiatry       Date:  2011-05-17       Impact factor: 15.992

8.  Suicidality and divalproex sodium: analysis of controlled studies in multiple indications.

Authors:  Laura Redden; Yili Pritchett; Weining Robieson; Xenia Kovacs; Mary Garofalo; Katherine Tracy; Mario Saltarelli
Journal:  Ann Gen Psychiatry       Date:  2011-01-18       Impact factor: 3.455

9.  Effect of unaffordable medical need on distress level of family member: analyses of 1997-2013 United States National Health Interview Surveys.

Authors:  Hui Jun Chih; Wenbin Liang
Journal:  BMC Psychiatry       Date:  2017-09-02       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.